- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04568187
Cryolipolysis Induced Gluteal Fat Change
Clinical Efficacy of Fat Reduction on the Thigh of Korean Women Through Cryolipolysis
There was no difference in efficacy in removal of local fat on thigh by cryolipolysis through Zeltiq machine.
Cryolipolysis was found to be safe for 12 week clinical trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
this study is conducted to investigate the clinical efficacy and safety of cryolipolysis on fat removal of thigh through cryolipolysis.
Healthy premenopausal volunteered women had been conducted to assess their anthropometrical, social, and cardio-metabolic, and femoral fat amount by computer tomography, and adverse events at initial, 4 week, 12 week visit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Bariatric clinic/Family medicine, Hong-Ik General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- pre-menopausal healthy women
- subjects with body mass index ≥ 18
- subjects with visible fat on both thigh
- subjects to understand and agree to this study protocol
Exclusion Criteria:
- subjects with cryoglobulinemia, cold urticaria, or paroxysmal cold hemogobulinemia
- subjects with pregnancy or lactation within 6 months or next 3 months
- subjects with any laboratory, or metabolic abnormalities
- uncooperative subjects to comply with the study protocol
- women taking any medication/ over the counter/herbal supplements to regulate weight or fat mass over 6 months
- subjects with menstrual irregularities
- subjects to change over 10% of the former weight within the past 6 months - any procedure such as liposuction, or another surgical procedure or mesotherapy to reduce fat within 6 months
- subjects with any dermatologic abnormalities on the target areas (thigh)
- subjects with any injection into the area of intended treatment (e.g. cortisone) within 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SEQUENTIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: cryolipolysis machine on Left inner thigh
Zeltiq machine as intervention procedure was carried out on left inner thigh (treated side) for 1 hour through cool sculpting procedure with CIF (Cooling Intensity Factor: -73 mW/cm2).
|
Zeltiq prototype device (Zeltiq Aesthetics, Pleasanton, CA) approved by FDA 2010
|
SHAM_COMPARATOR: radiofrequency on right thigh
The radio frequency method was applied on right thigh (control side) as sham procedure for 30 minutes through 3000 Hz- amplitude modulated frequency at once.
|
radiofrequency with 3000 Hz
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of girths in both thighs
Time Frame: 4 weeks
|
Comparison of circumferences of both thighs
|
4 weeks
|
The change of fat amounts in both thighs
Time Frame: 4 weeks
|
Comparison of cross-sectional areas in both thighs
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of girths in both thighs
Time Frame: 12 weeks
|
Comparison of circumferences of both thighs
|
12 weeks
|
The change of fat amounts in both thighs
Time Frame: 12 weeks
|
Comparison of cross-sectional areas in both thighs
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kyu R Lee, MD, PhD, Hongik General Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01177787
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Weight Changes
-
Pusan National University HospitalCompletedWeight Change, Body
-
Chiang Mai UniversityCompleted
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Washington University School of MedicineCompleted
-
Washington University School of MedicineCompletedWeight ChangeUnited States
-
Hacettepe UniversityCompleted
-
University Hospital Center of MartiniqueRecruiting
-
Huashan HospitalNot yet recruitingWeight Change, BodyChina
-
University of PittsburghTerminatedWeight Loss | Motor ActivityUnited States
-
Duke UniversityCompleted
Clinical Trials on zeltiq
-
Wonik Trade Company, KoreaCompletedCryotherapy Effect | LipolysisKorea, Republic of
-
Zeltiq AestheticsActive, not recruiting
-
Zeltiq AestheticsUnknown
-
Dermatology, Laser & Vein Specialists of the CarolinasUnknownGynecomastiaUnited States
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted